Ista Pharmaceuticals has agreed to pay $33.5 million to resolve charges that it promoted its anti-inflammatory drug Xibrom for unapproved uses in an effort to boost sales, the Justice Department said.
Procter & Gamble's A.G. Lafley, newly returned as CEO, must repopulate a depleted pool of top executives as he prepares a major overhaul and considers succession.
Syria's telecommunications providers continue to use technology by Blue Coat Systems to monitor Internet usage, according to Telecomix, a hacker-activist group that has tracked the previous use of the technology.